CliffBio
small molecule

SODIUM IODIDE I 131

SODIUM IODIDE I-131

Loss of exclusivity—loss of exclusivity
CompanyCurium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameSODIUM IODIDE I 131
Active ingredientSODIUM IODIDE I-131
Strength3.5-150mCi/VIAL
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from Curium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.